![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1666991
Ç×±Õ¼º ´Ü¹éÁú °¡¼öºÐÇØ¹° ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)Antimicrobial (Enzymatic) Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
½Äǰ ¹× ¹Ý·Áµ¿¹° »ç·á¿ë Ç×±Õ¼º ´Ü¹éÁú °¡¼öºÐÇØ¹° ¼¼°è ½ÃÀåÀº 2024³â 2¾ï 5,620¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ 7.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº ½Äǰ, Á¦¾à, ÆÛ½º³ÎÄÉ¾î µî »ê¾÷ Àü¹Ý¿¡ °ÉÃÄ Ãµ¿¬ ¹ÙÀÌ¿À ±â¹Ý Ç×±ÕÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.
¼ÒºñÀÚµéÀÌ ÇÕ¼º ¹æºÎÁ¦¿Í °ü·ÃµÈ À§ÇèÀ» ÀνÄÇÏ°Ô µÇ¸é¼ È¿¼Ò ´Ü¹éÁú °¡¼öºÐÇØ¹°Àº º¸Á¸ ±â°£ ¿¬Àå ¹× °Ç° Ư¼º Çâ»ó°ú °°Àº ±â´ÉÀû ÀÌÁ¡À¸·Î ÀÎÇØ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. Ç×±ÕÁ¦ ³»¼º¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö¸é¼ ¾÷°è´Â À¯ÇØÇÑ ¹Ì»ý¹°À» È¿°úÀûÀ¸·Î Á¦¾îÇÏ´Â °ÍÀ¸·Î ÀÔÁõµÈ ´Ü¹éÁú ±â¹Ý °¡¼öºÐÇØ¹°·Î ´«À» µ¹¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ý¸í°øÇÐÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ °¡¼öºÐÇØ¹°ÀÇ »ý»ê È¿À²ÀÌ Çâ»óµÇ°í °¡¿ë¼ºÀÌ ³ô¾ÆÁö¸é¼ ¿µ¾ç º¸ÃæÁ¦ ¹× µ¿¹° »ç·á¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ºÐ¾ß¿¡¼ äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 2¾ï 5,620¸¸ ´Þ·¯ |
¿¹»ó ±Ý¾× | 5¾ï 3,200¸¸ ´Þ·¯ |
CAGR | 7.4% |
Ç×±Õ¼º ´Ü¹éÁú °¡¼öºÐÇØ¹° ½ÃÀåÀº °ø±Þ¿øº°·Î ºÐ·ùµÇ¸ç, ÁÖ¿ä ºÎ¹®Àº ½Ä¹°, µ¿¹°, ¹Ì»ý¹°·Î ºÐ·ùµË´Ï´Ù. µ¿¹° À¯·¡ ºÎ¹®Àº 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¿© 1¾ï 4,990¸¸ ´Þ·¯¸¦ âÃâÇϰí 2034³â¿¡´Â 3¾ï 690¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »ý¼±, ¿ìÀ¯, °è¶õ¿¡¼ ¾òÀº µ¿¹°¼º ´Ü¹éÁúÀº dzºÎÇÑ ¾Æ¹Ì³ë»ê ÇÁ·ÎÇʰú Ç×±Õ ±â´ÉÀ» ³ªÅ¸³»´Â »ý¸®È°¼º ÆéŸÀ̵å·Î ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌµé ´Ü¹éÁúÀº ¾ÈÀü¼ºÀÌ ³ô°í À¯ÇØÇÑ ¹Ì»ý¹°ÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÏ´Â È¿°ú°¡ ÀÖ¾î ½Äǰ º¸Á¸ ¹× ÀǾàǰ¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
ÇüÅ¿¡ µû¶ó ½ÃÀåÀº ¾×ü, ºÐ¸», ÆäÀ̽ºÆ® Ä«Å×°í¸®·Î ³ª´¹´Ï´Ù. ºÐ¸» ÇüŰ¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, 2024³â 63%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ºÐ¸»Àº ¾ÈÁ¤¼ºÀÌ ³ô¾Æ ½Äǰ, ÀǾàǰ, ÈÀåǰ µî ´Ù¾çÇÑ »ê¾÷¿¡¼ ¿î¼Û ¹× Ãë±ÞÀÌ ¿ëÀÌÇÏ¿© ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤È®ÇÑ Åõ¿©°¡ °¡´ÉÇϱ⠶§¹®¿¡ Á¦Á¶¾÷ü´Â Á¦Á¦¸¦ ´õ Àß °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÐ¸» °¡¼öºÐÇØ¹°Àº ÀûÀÀ¼ºÀÌ ¶Ù¾î³ª¸ç, ¾×ü·Î À籸¼ºÇϰųª °Ç½Ä È¥ÇÕ¹°¿¡ ÷°¡ÇÒ ¼ö ÀÖ¾î ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼ ¼ºñ½º¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹ÀÇ ½Äǰ ¹× ¹Ý·Áµ¿¹° »ç·á¿ë Ç×±Õ(È¿¼Ò) ´Ü¹éÁú °¡¼öºÐÇØ¹° ½ÃÀåÀº 2024³â 5,790¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ÀÌ ½ÃÀåÀº ½ÄǰÀÇ Å¬¸° ¶óº§ õ¿¬ ¼ººÐ¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÇÕ¼º ¹æºÎÁ¦·ÎºÎÅÍÀÇ Àüȯ°ú Ç×±ÕÁ¦ ³»¼º¿¡ ´ëÇÑ ¿ì·ÁÀÇ Áõ°¡´Â ÀǾàǰ°ú °Ç°º¸Á¶½Äǰ ¸ðµÎ¿¡¼ ¹ÙÀÌ¿À ±â¹Ý Ç×±Õ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
The Global Antimicrobial Protein Hydrolysates Market for food and pet food applications amassed USD 256.2 million in 2024 and is projected to grow at a CAGR of 7.4% from 2025 to 2034. This growth is primarily driven by the increasing demand for natural, bio-based antimicrobial agents across industries such as food, pharmaceuticals, and personal care.
As consumers become more aware of the risks associated with synthetic preservatives, enzymatic protein hydrolysates are gaining popularity due to their functional benefits, including extended shelf life and enhanced health properties. The growing concern over antimicrobial resistance is prompting industries to turn to protein-based hydrolysates, which have been shown to effectively control harmful microorganisms. Furthermore, advances in biotechnology have improved the production efficiency of these hydrolysates, increasing their availability and supporting their adoption across various sectors, including nutraceuticals and animal feed.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $256.2 Million |
Forecast Value | $532 Million |
CAGR | 7.4% |
The antimicrobial protein hydrolysates market is categorized by source, with the main segments being plant, animal, and microorganisms. The animal-derived segment held the largest market share in 2024, generating USD 149.9 million, and is expected to reach USD 306.9 million by 2034. Animal-based proteins, sourced from fish, milk, and eggs, are highly valued for rich amino acid profiles and bioactive peptides, which show antimicrobial features. These proteins are widely used in food preservation and medications owing to their safety and effectiveness in inhibiting the growth of harmful microorganisms.
In terms of form, the market is divided into liquid, powder, and paste categories. The powder form leads the market, accounting for 63% share in 2024. Powders are preferred due to their stability, which makes them easier to transport and handle across different industries, including food, pharmaceuticals, and cosmetics. They also offer precise dosing, allowing manufacturers better control over formulations. Additionally, powdered hydrolysates are highly adaptable, as they can be reorganized into fluids or added to dry mixes, improving their serviceability in various applications.
U.S. antimicrobial (enzymatic) protein hydrolysates market for food and pet food applications was valued at USD 57.9 million in 2024. This market is growing rapidly due to increasing consumer demand for clean-label, natural ingredients in food products. The shift away from synthetic preservatives, along with heightened concerns about antimicrobial resistance, is further driving the demand for bio-based antimicrobial solutions in both pharmaceuticals and nutraceuticals.